Cancer tumor growth rate
Pro Research Analysisby 
Searched over 200M research papers
Tumor Growth Rate Models and Patterns in Cancer
Researchers use several mathematical models to describe how tumors grow, including exponential, power law, Gompertz, and logistic models. For breast and liver cancers, tumor growth often follows an exponential pattern, meaning the tumor size increases rapidly over time. In contrast, neurological cancers may grow according to a 2/3 power law, which suggests growth is more related to the tumor's surface area than its volume .
Tumor Doubling Time and Variation by Cancer Type
Tumor volume doubling time (TVDT) is a key measure of how quickly a tumor grows. Some cancers, such as testicular carcinomas, pediatric tumors, and certain mesenchymal tumors, can double in size within days, indicating very rapid growth. Other cancers, like those of the breast, prostate, and colon, tend to grow much more slowly, with doubling times measured in months or even years. Despite these differences, most tumors start from a single cell, have a long period before becoming clinically detectable, and often grow at a steady rate for extended periods. Metastases (secondary tumors) usually grow at a similar rate to the primary tumor 27.
Tumor Growth Rate as a Predictor of Clinical Outcomes
The rate at which a tumor grows before and during treatment is increasingly recognized as an important predictor of patient outcomes. In advanced non-small cell lung cancer (NSCLC) and small-cell lung cancer (SCLC), a higher pre-treatment or early on-treatment tumor growth rate (TGR) is linked to shorter progression-free survival (PFS) and overall survival (OS). Patients with lower TGRs tend to have better responses to immunotherapy and chemotherapy, while those with higher TGRs have worse outcomes 34568. This relationship holds true across different types of treatments, including immune checkpoint inhibitors and antibody-drug conjugates.
Tumor Growth Rate in Metastatic Disease
In metastatic cancers, such as brain metastases from breast and lung cancer, tumor growth rates can vary. For example, breast cancer brain metastases may grow at an average rate of 0.040 cm³ per day, while lung cancer brain metastases grow at about 0.018 cm³ per day. The doubling times for these tumors are approximately 86 days for breast cancer and 139 days for lung cancer. Faster-growing tumors are often associated with poorer survival .
Implications for Cancer Management and Research
Understanding tumor growth rates has important implications for cancer screening, treatment planning, and prognosis. Since many tumors are already several years old by the time they are detectable, the concept of "early detection" is complex. Tumor growth rate metrics can help tailor follow-up schedules, guide treatment decisions, and serve as intermediate endpoints in clinical trials to speed up drug development. However, some studies caution that while tumor growth rate is a useful biomarker, it should be benchmarked against traditional clinical endpoints to ensure its predictive value 2569.
Conclusion
Tumor growth rate is a critical factor in understanding cancer progression and predicting patient outcomes. Growth rates vary widely by cancer type and individual patient, but consistently, higher rates are linked to worse survival and treatment response. Measuring and monitoring tumor growth rate can help personalize cancer care and improve clinical trial design, but should be used alongside established clinical measures for the best results.
Sources and full results
Most relevant research papers on this topic